Hepatocellular Carcinoma Detection in Hepatitis C Virus-Related Cirrhosis by Glypican-3

Study of Glypican-3 in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

Diagnostic Accuracy of α-1-Acid Glycoprotein in Diagnosis of Hepatocellular Carcinoma

Value of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study

Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?

A COMPARATIVE STUDY OF THE DIAGNOSTIC AND PROGNOSTIC VALUE OF GOLGI PROTEIN 73 AND ALFA-FETO PROTEIN IN HEPATOCELLULAR CARCINOMA BEFORE AND AFTER THERAPEUTIC INTERVENTION

Predictive Value of Alpha-Fetoprotein Change Rates for Hepatocellular Carcinoma Recurrence After Liver Transplant

Evaluation of Testing of Serum Survivin and Alpha Fetoprotein in Patients with Hepatocellular Carcinoma and Hepatitis C Viral Infection

Evaluation of Testing of Serum Survivin and Alpha Fetoprotein in Patients with Hepatocellular Carcinoma and Hepatitis C Viral Infection

Evaluation of HCV-associated Hepatocellular Carcinoma based on Alpha-fetoprotein levels